Connecting academia and industry to accelerate hearing therapeutics
2 September 2023
Welcome to the 2023 Hearing Therapeutics Summit, a satellite event of the 58th Inner Ear Biology Meeting organised by RNID, UCL Ear Institute and UCLH NIHR BRC.
One in five adults in the UK have hearing loss and by 2035 it is estimated that there will be around 14.2 million adults in the UK alone living with hearing loss. Hearing loss has a significant impact on someone’s quality of life and is the largest modifiable risk factor for dementia. In recent years we have witnessed growing interest in developing therapeutics to meet this unmet clinical need, but many have failed in clinical trials.
This summit is a timely opportunity to reflect on what we have learned and discuss the challenges we face in developing treatments. Key to future success will be collaborative working between academia and industry, so we are delighted to be able to run this summit ahead of the Inner Ear Biology Workshop, helping to bring the research community together around the development of inner ear therapeutics.
We hope you enjoy the opportunity to learn and connect.
The Summit organising committee
Read more about our organising committee by clicking on their images below.
The RNID Hearing Therapeutics Initiative Network
The RNID Hearing Therapeutics Initiative accelerates the global development of new treatments and therapeutics to prevent and treat hearing loss and tinnitus.
The HTI Network
Satellite event of the 58th Inner Ear Biology Meeting